Search Results 501-510 of 13298 for Assay

  1. Mayo Clinic researchers identify a measurable genetic mutation as a significant predictor of metastasis and survival in pancreatic cancer

    Thus, the study suggests that ctDNA assays should be performed prior to treatment to have the highest yield. The researchers examined data between 2018 and ...

  2. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Serum free light chain (FLC) assay: involved FLC assay ≥ 10 mg/dL and an abnormal serum FLC ratio (< 0.26 or > 1.65). Patients with RR-NHL must be relapsed ...

  3. Hypoparathyroidism Clinical Trials - Mayo Clinic Research

    The purpose of this study is to collect patient samples to Ortho Clinical Diagnostics for evaluation of an in-development VITROS Intact PTH II assay and the ...

  4. Testing Low Dose Tamoxifen For Invasive Breast Cancer, The (LoTam) Trial - Mayo Clinic

    ... assay was obtained, both are required to be low-risk): * Oncotype DX recurrence score ≤ 25 * Mamma Print low risk * Prosigna risk of recurrence ≤ 40 * ...

  5. Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer - Mayo Clinic

    mutation) (MAF) less than 2% by Guardant360 assay. - Detection of at least one of the following gene mutation(s) or amplification(s) by. Guardant360 assay.

  6. Halting the circle: Comprehensive neurogenetics test panels - Mayo Clinic

    The detection of SRP-IgG is facilitated by a highly sensitive immunofluorescence-based assay that can discern the distinctive, characteristic pattern in a ...

  7. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay.

  8. Publications - Kevin C. Halling, M.D., Ph.D. - Mayo Clinic

    Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer Biomarkers. J Mol Diagn. 2025 Apr; 27 (4):292-305 Epub ...

  9. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay.

  10. Pediatrics Clinical Trials - Medical Professionals

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...